3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Withdrawn
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
10
Neoplasms
9
Polycystic Ovary Syndrome
8
Infertility
5
Liver Neoplasms
4
Pain, Postoperative
3
Neoplasm Metastasis
3
Multiple Myeloma
3
Lung Neoplasms
3
Head and Neck Neoplasms
3
Carcinoma, Hepatocellular
3
Urinary Bladder Neoplasms
2
Recurrence
2
Pulmonary Embolism
2
Prostatic Neoplasms
2
Pleural Effusion
2
Pancreatic Neoplasms
2
Ovarian Neoplasms
2
Neuroma, Acoustic
2
Melanoma
2
Lymphoma, Follicular
2
Leiomyoma
2
Inflammation
2
Febrile Neutropenia
2
Colorectal Neoplasms
2
Bites and Stings
2
Anovulation
2
Vomiting
1
Venous Thrombosis
1
Venous Thromboembolism
1
Interventions
dolutegravir
1
Ritonavir
1
Nucleosides
1
Darunavir
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Withdrawn
×
Coinfection
×
Clear all
NCT04183738
2020-11-10
i2-D²EFT
Kirby Institute
Phase 4
Withdrawn